Berlin, Germany

Jörg Peters



Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jörg Peters: Innovator in BiTE Pharmaceutical Compositions

Introduction

Jörg Peters, based in Berlin, Germany, is a notable inventor recognized for his contributions to the field of biopharmaceuticals. With a patent to his name, he has demonstrated an impactful presence in the innovative landscape of therapeutic development, particularly in creating formulations that enhance the efficacy of T-cell engagers.

Latest Patents

Peters holds a patent for a formulation focused on bispecific T-cell engagers (BiTEs). This invention specifically addresses the stability of pharmaceutical compositions that contain polypeptides with at least two antigen-binding domains. The notable aspect of his patent is the development of liquid compositions designed for subcutaneous administration, which effectively minimize the formation of undesirable polypeptide aggregates, enhancing the quality of the therapeutic solution.

Career Highlights

Jörg Peters is affiliated with Amgen Inc., where he continues to apply his expertise in biopharmaceutical innovation. His work primarily concentrates on improving the formulation and delivery methods of complex biopharmaceuticals, ensuring better patient outcomes. His single patent reflects his thorough understanding and innovative skills in tackling challenges presented by protein stability and aggregation.

Collaborations

During his career, Peters has collaborated with fellow researchers and professionals in his field, including colleagues Carsten Olbrich and Thomas Bunte. These collaborations are essential as they facilitate the exchange of ideas and innovations, driving forward the research and development of cutting-edge therapeutic solutions.

Conclusion

Jörg Peters exemplifies the spirit of innovation in the pharmaceutical industry. With his patented work on BiTE formulations, he is making significant strides in enhancing the stability and effectiveness of biotherapeutics. His ongoing collaborations and commitment to research underscore the importance of teamwork in driving advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…